Stroke Trial, Recruiting (NCT05237817)

Stroke Trial, Recruiting NCT05237817 Sponsor: Xuanwu Hospital, Beijing Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT05237817 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have had a stroke, including a blocked blood vessel in the brain (cerebral infarction), bleeding inside the brain (intracerebral hemorrhage), or bleeding around the brain (subarachnoid hemorrhage)

Who may not be able to join:

People with cancer that has spread to other parts of the body
People whose adrenal gland findings (growths found on the adrenal glands) are smaller than 1 cm in size
People whose adrenal gland findings are not a type called an adenoma — for example, those found to have myelolipomas, areas of bleeding, or cysts on the adrenal gland (confirm with trial site)
People who have taken steroid tablets (glucocorticoids) more than once in the past 3 months
People who use inhaled steroids or any medication that affects how a drug called dexamethasone is processed by the body
People who are taking estrogen as a systemic (whole-body) treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tong W Ou, Dr., Department of Urology, Xuanwu Hospital, Capital Medical University

Phone: +86-13651341058

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05237817

Sponsor: Xuanwu Hospital, Beijing

Phase: Not Applicable

Status: Recruiting

Condition: Stroke

Trial contact: +86-13651341058

More information: https://clinicaltrials.gov/study/NCT05237817

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have had a stroke, including a blocked blood vessel in the brain (cerebral infarction), bleeding inside the brain (intracerebral hemorrhage), or bleeding around the brain (subarachnoid hemorrhage)

Who may not be able to join:

People with cancer that has spread to other parts of the body
People whose adrenal gland findings (growths found on the adrenal glands) are smaller than 1 cm in size
People whose adrenal gland findings are not a type called an adenoma — for example, those found to have myelolipomas, areas of bleeding, or cysts on the adrenal gland (confirm with trial site)
People who have taken steroid tablets (glucocorticoids) more than once in the past 3 months
People who use inhaled steroids or any medication that affects how a drug called dexamethasone is processed by the body
People who are taking estrogen as a systemic (whole-body) treatment

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Xuanwu Hospital, Beijing

Registry

ClinicalTrials.gov

Start date

1 April 2021

Est. completion

1 April 2022

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Incidence rate of Adrenal incidentalomas; Plasma cortisol level

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov